Moderna CEO Says Skin Cancer Drug Launch in 2028 Is Possible
Moderna’s CEO said a launch in Germany and Europe of the company’s skin cancer drug in 2028 is a possibility.
Related stories
Ahold Delhaize to Acquire Tesco’s Czech and Slovak Operations
Ahold Delhaize will acquire Tesco’s operations in the Czech Republic and Slovakia.
M impact | EQUITY | Oct 30, 2026, 07:36 AM UTC
Varun Beverages Quarterly Profit Rises on Volume Growth
Packaging costs weighed on margins.
M impact | EQUITY | Oct 30, 2026, 07:35 AM UTC
Tesco Reports GBP2.9B Combined Sales in Czech Republic and Slovakia
M impact | EQUITY | Oct 30, 2026, 07:35 AM UTC
Panasonic Battery Unit Q2 Operating Profit Rises to 55.6 Billion Yen
Panasonic said operating profit at its energy unit rose from 1.2 billion yen a year earlier, citing higher sales of in-vehicle batteries and data centre energy storage systems. The
H impact | EQUITY | Oct 30, 2026, 07:35 AM UTC
Nikkei falls nearly 3% as technology shares retreat
The Nikkei fell nearly 3% as technology shares declined.
M impact | EQUITY | Oct 30, 2026, 07:34 AM UTC
Sanofi Raises 2026 Outlook as Q3 Earnings and Revenue Rise
Sanofi reported higher fiscal Q3 adjusted earnings and revenue and raised its 2026 outlook.
M impact | EQUITY | Oct 30, 2026, 07:33 AM UTC